We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Aspira Women's Health Inc (AWH) USD0.001

Sell:$3.10 Buy:$4.85 Change: $0.33 (9.62%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$3.10
Buy:$4.85
Change: $0.33 (9.62%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
Sell:$3.10
Buy:$4.85
Change: $0.33 (9.62%)
Market closed |  Prices as at close on 28 March 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Aspira Women's Health Inc. is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. Its products include Ova1, Overa, Ova1Plus and OvaWatch. Ova1 is a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical and radiological evaluation does not indicate malignancy. Overa is a biomarker reflex intended to maintain Ova1's high sensitivity while improving specificity. Ova1Plus is a reflex offering, which uses Ova1 as the primary test and Overa as a confirmation for Ova1 intermediate range results. OvaWatch is a lab developed blood test intended to assist in the initial clinical assessment of malignancy risk in all women with an adnexal mass. The Company’s products are distributed through its own national sales force, through its decentralized testing platform.

Contact details

Address:
Suite 100
12117 Bee Caves Road Building Three
AUSTIN
78738
United States
Telephone:
+1 (512) 5190400
Website:
https://aspirawh.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AWH
ISIN:
US04537Y2081
Market cap:
$35.46 million
Shares in issue:
10.34 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Nicole Sandford
    President, Chief Executive Officer, Director
  • Sandra Milligan
    President
  • Torsten Hombeck
    Chief Financial Officer
  • Michelle Snider
    Senior Vice President - Commercial Strategy and Operations
  • Minh Merchant
    General Counsel, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.